Feeder layer- and serum-free culture of human embryonic stem cells
- PMID: 14627547
- DOI: 10.1095/biolreprod.103.021147
Feeder layer- and serum-free culture of human embryonic stem cells
Abstract
In addition to their contribution to the research on early human development, human embryonic stem (hES) cells may also be used for cell-based therapies. Traditionally, these cells have been cultured on mouse embryonic fibroblast feeder layers, which allow their continuous growth in an undifferentiated state. However, the use of hES cells in human therapy requires an animal-free culture system, in which exposure to mouse retroviruses is avoided. In this study we present a novel feeder layer-free culture system for hES cells, based on medium supplemented with 15% serum replacement, a combination of growth factors including transforming growth factor beta1 (TGFbeta1), leukemia inhibitory factor, basic fibroblast growth factor, and fibronectin matrix. Human ES cells grown in these conditions maintain all ES cell features after prolonged culture, including the developmental potential to differentiate into representative tissues of the three embryonic germ layers, unlimited and undifferentiated proliferative ability, and maintenance of normal karyotype. The culture system presented here has two major advantages: 1) application of a well-defined culture system for hES cells and 2) reduced exposure of hES cells to animal pathogens. The feeder layer-free culture system reported here aims at facilitating research practices and providing a safer alternative for future clinical applications of hES cells.
Similar articles
-
Maintenance of human embryonic stem cells in animal serum- and feeder layer-free culture conditions.Methods Mol Biol. 2006;331:105-13. doi: 10.1385/1-59745-046-4:105. Methods Mol Biol. 2006. PMID: 16881512
-
Feeder-free culture of human embryonic stem cells.Methods Enzymol. 2006;420:37-49. doi: 10.1016/S0076-6879(06)20003-X. Methods Enzymol. 2006. PMID: 17161692
-
Human feeder layers for human embryonic stem cells.Biol Reprod. 2003 Jun;68(6):2150-6. doi: 10.1095/biolreprod.102.012583. Epub 2003 Jan 22. Biol Reprod. 2003. PMID: 12606388
-
Derivation, growth and applications of human embryonic stem cells.Reproduction. 2004 Sep;128(3):259-67. doi: 10.1530/rep.1.00243. Reproduction. 2004. PMID: 15333777 Review.
-
The development of 'feeder' cells for the preparation of clinical grade hES cell lines: challenges and solutions.J Biotechnol. 2006 Oct 1;125(4):583-8. doi: 10.1016/j.jbiotec.2006.03.011. Epub 2006 May 11. J Biotechnol. 2006. PMID: 16690155 Review.
Cited by
-
A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming.STAR Protoc. 2022 Aug 18;3(3):101560. doi: 10.1016/j.xpro.2022.101560. eCollection 2022 Sep 16. STAR Protoc. 2022. PMID: 36035804 Free PMC article. Review.
-
ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system.Cell Reprogram. 2010 Dec;12(6):641-53. doi: 10.1089/cell.2010.0051. Epub 2010 Sep 21. Cell Reprogram. 2010. PMID: 20858051 Free PMC article.
-
Development of Scalable Culture Systems for Human Embryonic Stem Cells.Biochem Eng J. 2010 Feb 15;48(3):378. doi: 10.1016/j.bej.2009.10.020. Biochem Eng J. 2010. PMID: 20161686 Free PMC article.
-
Decoding pluripotency: Genetic screens to interrogate the acquisition, maintenance, and exit of pluripotency.Wiley Interdiscip Rev Syst Biol Med. 2020 Jan;12(1):e1464. doi: 10.1002/wsbm.1464. Epub 2019 Aug 13. Wiley Interdiscip Rev Syst Biol Med. 2020. PMID: 31407519 Free PMC article. Review.
-
Gene Therapy: The Potential Applicability of Gene Transfer Technology to the Human Germline.Int J Med Sci. 2004;1(2):76-91. doi: 10.7150/ijms.1.76. Epub 2004 Jun 1. Int J Med Sci. 2004. PMID: 15912200 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous